State Medicaid Drug Utilization and Reimbursement Data 2024

U.S. Department of Health & Human Services provides State Drug Utilization Data for 2024, detailing Medicaid-covered outpatient drug purchases. The dataset includes state, drug name, National Drug Code, number of prescriptions, and dollars reimbursed. It is sourced from state reports to the Medicaid Drug Rebate Program.

Use Cases

• Analyze prescription volume and dollars reimbursed by state to identify regional drug utilization patterns.
• Track spending on specific drugs using National Drug Code and drug name for Medicaid cost analysis.
• Model reimbursement rates by correlating dollars reimbursed with number of prescriptions across states.

Strengths

• Data is reported by U.S. states, providing a national scope for Medicaid drug analysis.
• Includes key financial and utilization metrics: dollars reimbursed and number of prescriptions.
• Managed by the authoritative U.S. Department of Health & Human Services.

Limitations

• Specific row count, column count, and data size are unknown, limiting assessment of scale.
• Data is limited to Medicaid-covered outpatient drugs, excluding other payers or inpatient use.
• Relies on state reporting, which may introduce inconsistencies in data completeness or timeliness.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by state Medicaid agencies for covered outpatient drugs under the Medicaid Drug Rebate Program.

Time Range

2024

Freshness

Data was last updated in December 2025, indicating recent maintenance.

Geography

United States, by state